CN103432563A - Traditional Chinese medicine prescription for treating wind-cold type bronchial asthma - Google Patents

Abstract

The invention discloses a traditional Chinese medicine prescription for treating wind-cold type bronchial asthma. The traditional Chinese medicine prescription is characterized by consisting of ephedra, cassia twig, asarum, rhizoma zingiberis, semen brassicae, semen armeniacae amarae, common yam, perillaseed, schisandra chinensis, pinellia ternata breit, astragalus membranaceus, rhizoma atractylodis, pulp of dogwood fruit, radix pseudostellariae and medlar which are compatible. The traditional Chinese medicine prescription has the beneficial effects that the effect for treating the wind-cold type bronchial asthma is good; by clinically treating 603 illness cases, the effective rate is 97.18%, the cure rate is 81.90%, and the ineffective rate is only 2.82%; moreover, the traditional Chinese medicine prescription is quick to become effective and free of toxic and side effect; the process is simple and the treatment is convenient; the medicines are reasonable and scientific in compatibility; the prescription does not have a component for extremely overcoming harms and removing stasis as well as an agent with a strong pesticide effect including insects and the like, but the medicines complement with each other to achieve the effects of clearing lung and eliminating phlegm, stopping whoop and relieving asthma; the traditional Chinese medicine prescription has the effects of relieving cough and soothing the nerves, so that all symptoms can be effectively relieved.

Description

The Chinese medicinal formulae for the treatment of wind-cold type bronchial asthma

Technical field

The present invention relates to a kind of Chinese medicinal formulae, be specifically related to a kind of Chinese medicinal formulae for the treatment of wind-cold type bronchial asthma.

Background technology

Bronchial asthma (is called for short: asthma), be the chronic airway inflammation participated in by the multiple inflammatory cell such as eosinophilic granulocyte, mastocyte and T lymphocyte.This inflammation makes the susceptible person have airway hyperreactivity to various motivating factors, and can cause the air flue constriction, show as the symptoms such as the panting of repeated relapsing, dyspnea, uncomfortable in chest or cough, be everlasting night and (or) early morning outbreak, aggravation, extensively changeable reversible airflow limitation usually appears, but most of patients spontaneous remission or alleviate through treatment.It is a kind of commonly encountered diseases, frequently-occurring disease.At present, global asthmatic patient is 300,000,000 people approximately, Chinese patients with asthma approximately 3,000 ten thousand.Asthma is to affect the able-bodied important diseases of people, if treatment not in time, lack of standardization, asthma may be fatal.

The pathogenesis of asthma also imperfectly understands at present, but mainly comprises: allergy, chronic airway inflammation, airway hyperreactivity, air flue neuroregulation are not normal, genetic mechanism, respiratory virus infection, nerve signal Transduction Mechanism and airway remodeling and interaction thereof etc.

The common sympton of disease symptoms asthmatic patient be paroxysmally pant, the symptom such as out of breath, uncomfortable in chest or cough, small number of patients also may be take chest pain as main manifestations, these symptoms contact outbreak after the irritative gas such as smog, perfume, paint, dust, house pet, pollen or allergen through the patient that is everlasting, night and (or) early morning symptom also easily occur or aggravation.A lot of patient own audible and the sounds of stridulating when asthma attack.Symptom is normally paroxysmal, but most of patients spontaneous remission or alleviate through treatment.A lot of asthmatic patients usually experienced mistaken diagnosis process for a long time before making a definite diagnosis, be diagnosed as chronic bronchitis, pharyngitis etc., because wrong diagnosis causes the mistake of therapeutic scheme, delay treatment not only, cause the misery on health to the patient, also to the patient bring mentally, psychological misery, paying also economically wastes.

The method for the treatment of wind-cold type bronchial asthma has a lot, but mainly still: from the anti symptom treatment of relief of symptoms, to finding anaphylactogen, carry out desensitization treatment, then to reducing the air flue reaction.At present, people, when imposing above method, are also carrying out anti-inflammatory treatment, diminish inflammation, and prevent attacks diastole bronchus, reduce stimulating factor.

Yet, also exist following problem in clinical treatment:

1, the side effect of hormonal medicaments is very large;

2, some patients were is hormone tolerance type, and the hormone-sensitive person can show effect by Control of asthma after using hormonal medicaments, but can recur after stopping using;

3, all bronchi diastole agent all can not change bronchial pathological condition, thereby can not prevent the further deterioration of asthma.

Summary of the invention

For solving the deficiencies in the prior art, the object of the present invention is to provide a kind for the treatment of both the principal and secondary aspects of a disease, relieving asthma, eliminate the phlegm, antitussive, the Chinese medicinal formulae that is used for the treatment of wind-cold type bronchial asthma of calming the nerves.

In order to realize above-mentioned target, the present invention adopts following technical scheme:

A kind of Chinese medicinal formulae for the treatment of wind-cold type bronchial asthma, is characterized in that, the material combination of following weight proportion, consists of:

Herba Ephedrae 3-5 part, Ramulus Cinnamomi 3-5 part, Herba Asari 2-3 part, Rhizoma Zingiberis 2-4 part, Semen Sinapis Albae 4-6 part, Semen Armeniacae Amarum 7-9 part, Rhizoma Dioscoreae 14-16 part, Fructus Perillae 4-6 part, Fructus Schisandrae Chinensis 4-6 part, Rhizoma Pinelliae Preparata 7-9 part, Radix Astragali 17-19 part, Rhizoma Atractylodis Macrocephalae 14-16 part, Fructus Corni 9-11 part, Radix Pseudostellariae 9-11 part, Fructus Lycii 11-13 part.

The Chinese medicinal formulae of aforesaid treatment wind-cold type bronchial asthma, is characterized in that, the material combination of following weight proportion, consists of:

4 parts, Herba Ephedrae, 4 parts of Ramulus Cinnamomi, 2 parts of Herba Asaris, 3 parts of Rhizoma Zingiberiss, 5 parts of Semen Sinapis Albaes, 8 parts of Semen Armeniacae Amarums, 15 parts of Rhizoma Dioscoreaes, 5 parts of Fructus Perillaes, 5 parts of Fructus Schisandrae Chinensis, 8 parts of Rhizoma Pinelliae Preparata, 18 parts of the Radixs Astragali, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Fructus Corni, 10 parts of Radix Pseudostellariaes, 12 parts of Fructus Lyciis.

Usefulness of the present invention is: treatment wind-cold type bronchial asthma is effective, and through the routine case of clinical treatment 603, effective percentage is 97.18%, and cure rate is 81.90%, inefficiency only 2.82%, and instant effect, have no side effect; Technique is simple, and treatment is convenient; Medication is reasonable, compatibility science: Herba Ephedrae diaphoresis cold expelling, depressed lung-energy dispersing, Ramulus Cinnamomi diaphoresis expelling pathogenic factors from muscles, dispersing cold for relieving pain, Herba Asari induce sweat cold expelling, warming the lung to resolve fluid-retention, the therapeutic method to keep the adverse QI flowing downwards eliminate the phlegm, sensible, Rhizoma Zingiberis warming spleen and stomach for dispelling cold, dampness expectorant, warming the lung to resolve fluid-retention, Semen Sinapis Albae warming the lung, eliminating phlegm, regulate the flow of vital energy, Semen Armeniacae Amarum sending down the abnormal ascending QI, cough-relieving, relieving asthma, Rhizoma Dioscoreae spleen reinforcing nourishing the stomach, lung benefiting promotes the production of body fluid, the Fructus Perillae therapeutic method to keep the adverse QI flowing downwards, clearing away phlegm, lung moistening, the Rhizoma Pinelliae Preparata drying dampness to eliminate phlegm, Rhizoma Atractylodis Macrocephalae invigorating the spleen and regulating the stomach, reduce phlegm, hidroschesis, Radix Pseudostellariae is mended strengthening spleen and lung, supplementing QI for promoting the production of body fluid, Fructus Lycii nourishing the liver and kidney, replenishing vital essence to improve eyesight; This prescription cuts down the product of heavily fortified point that disappear without excessive gram, again without the high violent agent of insects, but all medicines mutually 5 bring out the best in each other, and play altogether the effect that respectful lung reduces phlegm, only heavy breathing is relievingd asthma, and the effect of simultaneously also have antitussive, calming the nerves, can effectively alleviate all diseases.

The specific embodiment

Below in conjunction with specific embodiment, the present invention is done to concrete introduction.

One, prescription preparation

The formula table of table 1 prescription

?

Formula 1

Formula 2

Formula 3

Herba Ephedrae	3	4	5
				Ramulus Cinnamomi	3	4	5
Herba Asari	2	2	3
				Rhizoma Zingiberis	2	3	4
Semen Sinapis Albae	4	5	6
				Semen Armeniacae Amarum	7	8	9
Rhizoma Dioscoreae	14	15	16
				Fructus Perillae	4	5	6
Fructus Schisandrae Chinensis	4	5	6
				Rhizoma Pinelliae Preparata	7	8	9
The Radix Astragali	17	18	19
				The Rhizoma Atractylodis Macrocephalae	14	15	16
Fructus Corni	9	10	11
				Radix Pseudostellariae	9	10	11
Fructus Lycii	11	12	13

Two, administrated method

The medicinal marmite of above-mentioned raw materials is endured 2 times, and the water added for the first time is advisable to exceed 3 centimeters of medicines, and two decoct to add water to and flood powder for well, endure at every turn and get final product in 30 minutes.Then the medicinal liquid of enduring for 2 times is drinking mixed, 2 Ci ∕ days, 1 Ji ∕ day 7～10 days was a course for the treatment of.Treat 3-6 the course for the treatment of continuously.

Three, case is selected

1206 routine cases all come from January, the 2009～2011 year December Respiratory Medicine out-patient of Affiliated Hospital of Yanan University.Be divided into treatment group and each 603 examples of matched group by the table of random number method.

Treatment group: 3～69 years old age, average (58.5 ± 9.5) year; Disease time 2～10 minutes, average (5.9 ± 4.1) minute.

Matched group: age 10-66 year, average (43.8 ± 5.4) year; Disease time 3～10 minutes, average (7.0 ± 3.7) minute.

Four, the criterion of curative effect

The criterion of curative effect is formulated with reference to " clinical disease diagnosis is according to curing the improvement standard " and " traditional Chinese medical science disease Standardization of diagnosis and curative effect ".

(1), clinic control: symptoms of asthma is alleviated fully, even even, has slight outbreak not need medication to alleviate.FEV1 (or PEF) recruitment > 35%, or FEV1 (PEF) >=80% predicted value after treatment.PEF day and night fluctuation rate<20%;

(2), produce effects: asthma attack obviously alleviates before treating, FEV1 (or PEF) recruitment scope 25%～35%, or after treatment, FEV1 (PEF) reaches 60%～79% of predicted value, PEF day and night fluctuation rate<20%, still need with glucocorticoid or bronchodilator;

(3), take a turn for the better: symptoms of asthma alleviates to some extent, FEV1(or PEF) recruitment 15%～24%, still need with glucocorticoid and (or) bronchodilator;

(4), invalid: clinical symptoms and FEV1 (or PEF) measured value is without improving or increasing the weight of on the contrary.

Five, efficacy result analysis

Through treating 3-6 the course for the treatment of continuously, in 603 routine cases for the treatment of group:

1., symptoms of asthma alleviates to some extent, obviously alleviates or alleviation person fully, amounts to 586 examples, effective percentage 97.18%;

2., symptoms of asthma alleviates fully, even even, has slight outbreak also not need the medication can alleviation person, amounts to 489 examples, cure rate 81.09%;

3., symptoms of asthma is without the improver, amounts to 17 examples, inefficiency 2.82%.

Hence one can see that, the Chinese medicinal formulae for the treatment of wind-cold type bronchial asthma of the present invention, and its therapeutic effect is good, instant effect, cure rate are high, is a kind of comparatively desirable Chinese medicinal formulae of wind-cold type bronchial asthma for the treatment of.

It should be noted that, above-described embodiment does not limit the present invention in any form, and all employings are equal to replaces or technical scheme that the mode of equivalent transformation obtains, all drops in protection scope of the present invention.

Claims (2)

1. the Chinese medicinal formulae for the treatment of wind-cold type bronchial asthma, is characterized in that, the material combination of following weight proportion, consists of:

Herba Ephedrae 3-5 part, Ramulus Cinnamomi 3-5 part, Herba Asari 2-3 part, Rhizoma Zingiberis 2-4 part, Semen Sinapis Albae 4-6 part, Semen Armeniacae Amarum 7-9 part, Rhizoma Dioscoreae 14-16 part, Fructus Perillae 4-6 part, Fructus Schisandrae Chinensis 4-6 part, Rhizoma Pinelliae Preparata 7-9 part, Radix Astragali 17-19 part, Rhizoma Atractylodis Macrocephalae 14-16 part, Fructus Corni 9-11 part, Radix Pseudostellariae 9-11 part, Fructus Lycii 11-13 part.

2. the Chinese medicinal formulae for the treatment of wind-cold type bronchial asthma according to claim 1, is characterized in that, the material combination of following weight proportion, consists of:

4 parts, Herba Ephedrae, 4 parts of Ramulus Cinnamomi, 2 parts of Herba Asaris, 3 parts of Rhizoma Zingiberiss, 5 parts of Semen Sinapis Albaes, 8 parts of Semen Armeniacae Amarums, 15 parts of Rhizoma Dioscoreaes, 5 parts of Fructus Perillaes, 5 parts of Fructus Schisandrae Chinensis, 8 parts of Rhizoma Pinelliae Preparata, 18 parts of the Radixs Astragali, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Fructus Corni, 10 parts of Radix Pseudostellariaes, 12 parts of Fructus Lyciis.